CIK 0001739410
- Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851083789
- Phone
- +1 203-859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-27 | Uden Stephen Chief Executive Officer | Exercise or conversion | +33,244 | $6.08 | $202K | 148,864 |
| 2026-10-27 | Uden Stephen Chief Executive Officer | Exercise or conversion · Option (Right to Buy) | −33,244 | 0 | ||
| 2026-10-06 | Uden Stephen Chief Executive Officer | Exercise or conversion | +22,456 | $6.08 | $137K | 115,620 |
| 2026-10-06 | Uden Stephen Chief Executive Officer | Exercise or conversion · Option (Right to Buy) | −22,456 | 0 | ||
| 2025-02-14 | Uden Stephen Chief Executive Officer | Grant or award · Option (Right to Buy) | +453,700 | 453,700 | ||
| 2024-02-15 | Uden Stephen Chief Executive Officer | Grant or award · Option (Right to Buy) | +216,000 | 216,000 | ||
| 2023-02-06 | Uden Stephen | Grant or award · Option (Right to Buy) | +214,000 | 214,000 | ||
| 2022-02-07 | Uden Stephen | Grant or award · Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-01-13 | Uden Stephen | Purchase | +4,193 | $9.06 | $38K | 718,320 |
| 2022-01-13 | Uden Stephen | Purchase | +807 | $9.62 | $8K | 719,127 |
| 2022-01-12 | Uden Stephen | Purchase | +5,000 | $10.55 | $53K | 714,127 |
| 2021-07-28 | Uden Stephen | Other acquisition | +709,127 | 709,127 | ||
| 2021-07-28 | Uden Stephen | Other disposition · Common Units | −4,820,000 | 0 | ||
| 2021-07-28 | Uden Stephen | Other disposition · Series A-1 Preferred Units | −150,000 | 0 | ||
| 2021-07-28 | Uden Stephen | Other disposition · Series A-2 Preferred Units | −100,000 | 0 | ||
| 2021-07-28 | Uden Stephen | Other disposition · Series B Preferred Units | −107,891 | 0 | ||
| 2021-07-28 | Uden Stephen | Grant or award · Option (Right to Buy) | +160,000 | 160,000 |
Page 1 of 1 · 17 trades